Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W H Kay

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
The New England Journal of Medicine|December 6, 2023
Baricitinib and β-Cell Function in Patients with New-Onset Type 1 DiabetesMichaela Waibel, John M Wentworth, Michelle So, et al.
Internal Medicine Journal|October 21, 2022
Diabetes IN hospital - Glucose and Outcomes in the COVID-19 pandemic (DINGO COVID-19): the 2020 Melbourne hospital experience prior to novel variants and vaccinationsRahul D Barmanray, Joanna Y Gong, Mervyn Kyi, et al.
Diabetes Care|December 27, 2023
Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 DiabetesJohn Virostko, Jordan J Wright, Jonathan M Williams, et al.
Diabetes|July 23, 2017
Granzyme A Deficiency Breaks Immune Tolerance and Promotes Autoimmune Diabetes Through a Type I Interferon-Dependent PathwayZia U A Mollah, Hong Sheng Quah, Kate L Graham, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 18, 2018
Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Transplantation|March 13, 2018
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders WorkshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Transplantation|April 16, 2016
Executive Summary of IPITA-TTS Opinion Leaders Report on the Future of β-Cell ReplacementJames F Markmann, Stephen T Bartlett, Paul Johnson, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
The New England Journal of Medicine|December 6, 2023
Baricitinib and β-Cell Function in Patients with New-Onset Type 1 DiabetesMichaela Waibel, John M Wentworth, Michelle So, et al.
Internal Medicine Journal|October 21, 2022
Diabetes IN hospital - Glucose and Outcomes in the COVID-19 pandemic (DINGO COVID-19): the 2020 Melbourne hospital experience prior to novel variants and vaccinationsRahul D Barmanray, Joanna Y Gong, Mervyn Kyi, et al.
Diabetes Care|December 27, 2023
Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 DiabetesJohn Virostko, Jordan J Wright, Jonathan M Williams, et al.
Diabetes|July 23, 2017
Granzyme A Deficiency Breaks Immune Tolerance and Promotes Autoimmune Diabetes Through a Type I Interferon-Dependent PathwayZia U A Mollah, Hong Sheng Quah, Kate L Graham, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 18, 2018
Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Transplantation|March 13, 2018
Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders WorkshopMichael R Rickels, Peter G Stock, Eelco J P de Koning, et al.
Transplantation|April 16, 2016
Executive Summary of IPITA-TTS Opinion Leaders Report on the Future of β-Cell ReplacementJames F Markmann, Stephen T Bartlett, Paul Johnson, et al.
Pageof 10